Incannex Healthcare Inc.

NasdaqGM:IXHL Stock Report

Market Cap: US$32.3m

Incannex Healthcare Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IXHL?
Owner TypeNumber of SharesOwnership Percentage
Private Companies683,9493.88%
Institutions693,5703.93%
Individual Insiders3,536,02720%
General Public12,729,28672.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.1%.


Top Shareholders

Top 23 shareholders own 27.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.94%
Joel Latham
1,577,485US$2.9m0%no data
4.36%
George Anastassov
769,721US$1.4m0%no data
4.25%
Troy Valentine
749,250US$1.4m1.35%no data
3.62%
Prasch B.V.
639,549US$1.2m0%no data
1.54%
Peter Widdows
270,847US$495.7k0%no data
1.38%
Alignment Capital Pty Ltd, Asset Management Arm
242,862US$444.4k0%71.36%
0.74%
Tidal Investments LLC
130,026US$237.9k-53.7%no data
0.72%
AdvisorShares Investments, LLC
126,990US$232.4k58.7%0.04%
0.57%
Robert Clark
100,000US$183.0k0%no data
0.39%
Joseph Swan
68,724US$125.8k0%no data
0.25%
Cityside Investments Pty Ltd.
44,400US$81.3k0%no data
0.22%
Morgan Stanley, Investment Banking and Brokerage Investments
38,853US$71.1k30.2%no data
0.21%
Virtu Financial LLC, Asset Management Arm
36,622US$67.0k0%no data
0.14%
Bridgeway Capital Management, LLC
25,000US$45.7k0%no data
0.14%
Citadel Advisors LLC
24,152US$44.2k0%no data
0.13%
Hudson River Trading LLC, Asset Management Arm
23,752US$43.5k-45.9%no data
0.13%
Barclays Bank PLC, Securities Investments
22,502US$41.2k0%no data
0.063%
Squarepoint OPS LLC
11,132US$20.4k0%no data
0.045%
Geode Capital Management, LLC
7,892US$14.4k-0.88%no data
0.017%
UBS Asset Management AG
2,935US$5.4k-51.1%no data
0.0045%
1st Capital Management Group GmbH
800US$1.5k0%0.17%
0.00028%
Catalyst Funds Management Pty Ltd
50US$90.40%no data
0.00001%
JPMorgan Chase & Co, Brokerage and Securities Investments
2US$3.20%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 03:48
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Incannex Healthcare Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Arron AatkarEdison Investment Research
David Joseph StormsStonegate Capital Partners, Inc.